FI911783A0 - Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer - Google Patents

Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer

Info

Publication number
FI911783A0
FI911783A0 FI911783A FI911783A FI911783A0 FI 911783 A0 FI911783 A0 FI 911783A0 FI 911783 A FI911783 A FI 911783A FI 911783 A FI911783 A FI 911783A FI 911783 A0 FI911783 A0 FI 911783A0
Authority
FI
Finland
Prior art keywords
butynylamines
oxothiazolidinyl
preparation
therapeutically useful
therapeutically
Prior art date
Application number
FI911783A
Other languages
English (en)
Finnish (fi)
Other versions
FI94755B (sv
FI94755C (sv
FI911783A (sv
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI911783A0 publication Critical patent/FI911783A0/sv
Publication of FI911783A publication Critical patent/FI911783A/sv
Publication of FI94755B publication Critical patent/FI94755B/sv
Application granted granted Critical
Publication of FI94755C publication Critical patent/FI94755C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FI911783A 1990-04-16 1991-04-12 Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer FI94755C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/509,280 US5034392A (en) 1990-04-16 1990-04-16 4-(3-(4-oxothiazolidinyl)butynylamines
US50928090 1990-04-16

Publications (4)

Publication Number Publication Date
FI911783A0 true FI911783A0 (sv) 1991-04-12
FI911783A FI911783A (sv) 1991-10-17
FI94755B FI94755B (sv) 1995-07-14
FI94755C FI94755C (sv) 1995-10-25

Family

ID=24025983

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911783A FI94755C (sv) 1990-04-16 1991-04-12 Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer

Country Status (26)

Country Link
US (1) US5034392A (sv)
EP (1) EP0452850B1 (sv)
JP (1) JPH07119223B2 (sv)
KR (1) KR0163598B1 (sv)
AR (1) AR248402A1 (sv)
AT (1) ATE163010T1 (sv)
AU (1) AU636972B2 (sv)
BG (1) BG60066B2 (sv)
CA (1) CA2040489C (sv)
CZ (1) CZ284447B6 (sv)
DE (1) DE69128845T2 (sv)
DK (1) DK0452850T3 (sv)
ES (1) ES2112844T3 (sv)
FI (1) FI94755C (sv)
GR (1) GR3026319T3 (sv)
HU (1) HUT61017A (sv)
IE (1) IE911257A1 (sv)
IL (1) IL97852A (sv)
MX (1) MX25359A (sv)
NO (1) NO300134B1 (sv)
NZ (1) NZ237811A (sv)
PL (1) PL165488B1 (sv)
PT (1) PT97371B (sv)
RO (1) RO108683B1 (sv)
RU (1) RU2001914C1 (sv)
ZA (1) ZA912783B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273977A (en) * 1990-11-05 1993-12-28 Warner-Lambert Company Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.

Also Published As

Publication number Publication date
FI94755B (sv) 1995-07-14
ATE163010T1 (de) 1998-02-15
PL165488B1 (pl) 1994-12-30
US5034392A (en) 1991-07-23
PL289892A1 (en) 1992-07-27
MX25359A (es) 1994-05-31
PT97371A (pt) 1992-01-31
KR910018367A (ko) 1991-11-30
DE69128845D1 (de) 1998-03-12
CZ284447B6 (cs) 1998-11-11
AU7502891A (en) 1991-10-17
JPH04234879A (ja) 1992-08-24
NO911465D0 (no) 1991-04-15
DK0452850T3 (da) 1998-09-23
HU911239D0 (en) 1991-10-28
NO300134B1 (no) 1997-04-14
IL97852A0 (en) 1992-06-21
FI94755C (sv) 1995-10-25
RU2001914C1 (ru) 1993-10-30
GR3026319T3 (en) 1998-06-30
DE69128845T2 (de) 1998-07-09
AR248402A1 (es) 1995-08-18
AU636972B2 (en) 1993-05-13
PT97371B (pt) 1998-08-31
JPH07119223B2 (ja) 1995-12-20
FI911783A (sv) 1991-10-17
BG60066B2 (bg) 1993-09-30
EP0452850B1 (en) 1998-02-04
ES2112844T3 (es) 1998-04-16
IE911257A1 (en) 1991-10-23
EP0452850A1 (en) 1991-10-23
KR0163598B1 (ko) 1998-12-01
ZA912783B (en) 1991-12-24
CS9101065A2 (en) 1991-11-12
RO108683B1 (ro) 1994-07-29
CA2040489C (en) 2003-06-10
HUT61017A (en) 1992-11-30
NZ237811A (en) 1993-12-23
CA2040489A1 (en) 1991-10-17
NO911465L (no) 1991-10-17
IL97852A (en) 1994-11-28

Similar Documents

Publication Publication Date Title
FI905941A (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
FI104170B1 (sv) Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI880941A (sv) Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
IS3529A7 (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkum bis-aza-bísýklískum efnasamböndum
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
FI890245A (sv) Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat
FI930723A0 (sv) Förfarande för framställning av terapeutiskt aktiva tiazolidinderivat
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI880716A0 (sv) Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar
FI911420A (sv) Förfarande för framställning av terapeutiskt användbara föreningar
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI911701A0 (sv) Förfarande för framställning av terapeutiskt användbara 2-substituerade-3-karboxikarbapenemer
NO177712C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI911783A (sv) Förfarande för framställning av terapeutiskt användbara 4-/3-(4-oxotiazolidinyl)/butynylaminer
NO177710C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger
NO179367C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser
FI882836A0 (sv) Förfarande för framställning av terapeutiskt användbar (E)-2-(p-fluorfenetyl)-3-fluorallylamin

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.

MA Patent expired